Clinical Trials Directory

Trials / Completed

CompletedNCT04615026

Prevalence of Thrombosis in COVID-Patients

Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity

Status
Completed
Phase
Study type
Observational
Enrollment
525 (actual)
Sponsor
University Hospital Augsburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Examination of the prevalence of thrombosis in COVID-patients, especially in an out-patient setting. Assessment by duplex sonography. If thrombosis is detected, we will correlate it with immunity status. Assessment of health issues and cognitive function as late complication after infection.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTduplex sonographyall patients with consent receive a duplex ultrasound, blood test, cognitive test and test of smelling

Timeline

Start date
2020-11-04
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2020-11-04
Last updated
2022-06-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04615026. Inclusion in this directory is not an endorsement.

Prevalence of Thrombosis in COVID-Patients (NCT04615026) · Clinical Trials Directory